1. Home
  2. ABVX vs WIW Comparison

ABVX vs WIW Comparison

Compare ABVX & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • WIW
  • Stock Information
  • Founded
  • ABVX 2013
  • WIW 2004
  • Country
  • ABVX France
  • WIW United States
  • Employees
  • ABVX N/A
  • WIW N/A
  • Industry
  • ABVX
  • WIW Finance Companies
  • Sector
  • ABVX
  • WIW Finance
  • Exchange
  • ABVX Nasdaq
  • WIW Nasdaq
  • Market Cap
  • ABVX 511.3M
  • WIW 521.9M
  • IPO Year
  • ABVX N/A
  • WIW N/A
  • Fundamental
  • Price
  • ABVX $7.90
  • WIW $8.79
  • Analyst Decision
  • ABVX Buy
  • WIW
  • Analyst Count
  • ABVX 4
  • WIW 0
  • Target Price
  • ABVX $31.50
  • WIW N/A
  • AVG Volume (30 Days)
  • ABVX 254.8K
  • WIW 229.9K
  • Earning Date
  • ABVX 08-11-2025
  • WIW 01-01-0001
  • Dividend Yield
  • ABVX N/A
  • WIW 11.14%
  • EPS Growth
  • ABVX N/A
  • WIW N/A
  • EPS
  • ABVX N/A
  • WIW N/A
  • Revenue
  • ABVX $11,444,012.00
  • WIW N/A
  • Revenue This Year
  • ABVX $284.20
  • WIW N/A
  • Revenue Next Year
  • ABVX N/A
  • WIW N/A
  • P/E Ratio
  • ABVX N/A
  • WIW N/A
  • Revenue Growth
  • ABVX 128.98
  • WIW N/A
  • 52 Week Low
  • ABVX $4.77
  • WIW $8.01
  • 52 Week High
  • ABVX $14.16
  • WIW $9.37
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 65.58
  • WIW 70.27
  • Support Level
  • ABVX $7.41
  • WIW $8.73
  • Resistance Level
  • ABVX $8.13
  • WIW $8.80
  • Average True Range (ATR)
  • ABVX 0.43
  • WIW 0.05
  • MACD
  • ABVX 0.12
  • WIW 0.02
  • Stochastic Oscillator
  • ABVX 92.21
  • WIW 96.23

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About WIW Western Asset Inflation-Linked Opportunities & Income Fund

Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.

Share on Social Networks: